Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Marx

Showing results (481-490 of 657) with videos related to

Pageof 66
Sort By:
The Lancet. Global Health|November 19, 2021
Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelaeNicolas A Menzies, Matthew Quaife, Brian W Allwood, et al.
BMJ (Clinical Research Ed.)|June 8, 2023
Practical thematic analysis: a guide for multidisciplinary health services research teams engaging in qualitative analysisCatherine H Saunders, Ailyn Sierpe, Christian von Plessen, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Mutations in the HFE gene and cardiovascular disease risk: an individual patient data meta-analysis of 53 880 subjectsDaphne L van der A, Maroeska M Rovers, Diederick E Grobbee, et al.
British Journal of Cancer|April 14, 2015
Cytokine profiling of docetaxel-resistant castration-resistant prostate cancerK L Mahon, H-M Lin, L Castillo, et al.
Open Forum Infectious Diseases|January 15, 2024
Reducing Initial Loss to Follow-up Among People With Bacteriologically Confirmed Tuberculosis: LINKEDin, a Quasi-experimental Study in South AfricaSue-Ann Meehan, Anneke C Hesseling, Andrew Boulle, et al.
Asia-Pacific Journal of Clinical Oncology|October 2, 2018
The impact and indications for Oncotype DX on adjuvant treatment recommendations when third-party funding is unavailableL Chin-Lenn, R H De Boer, E Segelov, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|June 18, 2021
Guidelines of the French Society of Otorhinolaryngology-Head and Neck Surgery (SFORL) and the French Society of Audiology (SFA) for Speech-in-Noise Testing in AdultsC-A Joly, P Reynard, K Mezzi, et al.
The Lancet. Global Health|June 14, 2024
Diagnostic yield as an important metric for the evaluation of novel tuberculosis tests: rationale and guidance for future researchTobias Broger, Florian M Marx, Grant Theron, et al.
Future Oncology (London, England)|January 17, 2025
Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304)Ciara Conduit, Andrisha-Jade Inderjeeth, Raymond Allen, et al.
Journal of Medicinal Chemistry|September 27, 2024
Identification of Potent, Broad-Spectrum Coronavirus Main Protease Inhibitors for Pandemic PreparednessDavid T Barkan, Keira Garland, Lei Zhang, et al.
Pageof 66

Showing results (481-490 of 657) with videos related to

Sort By:
Pageof 66
The Lancet. Global Health|November 19, 2021
Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelaeNicolas A Menzies, Matthew Quaife, Brian W Allwood, et al.
BMJ (Clinical Research Ed.)|June 8, 2023
Practical thematic analysis: a guide for multidisciplinary health services research teams engaging in qualitative analysisCatherine H Saunders, Ailyn Sierpe, Christian von Plessen, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Mutations in the HFE gene and cardiovascular disease risk: an individual patient data meta-analysis of 53 880 subjectsDaphne L van der A, Maroeska M Rovers, Diederick E Grobbee, et al.
British Journal of Cancer|April 14, 2015
Cytokine profiling of docetaxel-resistant castration-resistant prostate cancerK L Mahon, H-M Lin, L Castillo, et al.
Open Forum Infectious Diseases|January 15, 2024
Reducing Initial Loss to Follow-up Among People With Bacteriologically Confirmed Tuberculosis: LINKEDin, a Quasi-experimental Study in South AfricaSue-Ann Meehan, Anneke C Hesseling, Andrew Boulle, et al.
Asia-Pacific Journal of Clinical Oncology|October 2, 2018
The impact and indications for Oncotype DX on adjuvant treatment recommendations when third-party funding is unavailableL Chin-Lenn, R H De Boer, E Segelov, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|June 18, 2021
Guidelines of the French Society of Otorhinolaryngology-Head and Neck Surgery (SFORL) and the French Society of Audiology (SFA) for Speech-in-Noise Testing in AdultsC-A Joly, P Reynard, K Mezzi, et al.
The Lancet. Global Health|June 14, 2024
Diagnostic yield as an important metric for the evaluation of novel tuberculosis tests: rationale and guidance for future researchTobias Broger, Florian M Marx, Grant Theron, et al.
Future Oncology (London, England)|January 17, 2025
Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304)Ciara Conduit, Andrisha-Jade Inderjeeth, Raymond Allen, et al.
Journal of Medicinal Chemistry|September 27, 2024
Identification of Potent, Broad-Spectrum Coronavirus Main Protease Inhibitors for Pandemic PreparednessDavid T Barkan, Keira Garland, Lei Zhang, et al.
Pageof 66